510(k) device
Cardiac Guidance
Caption Health, Inc. · Image Acquisition And/Or Optimization Guided By Artificial Intelligence (QJU, Class II) · First FDA decision Jan 15, 2025, newest Jan 15, 2025
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1,686
Naming "Guidance"
MAUDE reports
463
Brand "Guidance", since 2015
PubMed studies
243,407
Mentioning "Guidance"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cardiac Guidance
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Cardiac Guidance510(k)
K243065 · Decided Jan 15, 2025 · 110 days after receipt
Device type: Image Acquisition And/Or Optimization Guided By Artificial Intelligence (QJU) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Image-Guided Lumbar Decompression for Lumbar Spinal StenosisNational determinationOn the books150.13Updated Nov 5, 2026
- Percutaneous Image-guided Lumbar Decompression for Lumbar Spinal StenosisNational analysisReview closedCAG-00433RUpdated Sep 21, 2026
- Percutaneous Image-guided Lumbar Decompression for Lumbar Spinal StenosisNational analysisReview closedCAG-00433NUpdated Sep 21, 2026
- Breast Biopsy (Percutaneous Image Guided) for Palpable LesionsNational analysisReview closedCAG-00074NUpdated Sep 14, 2026
- Percutaneous Image-Guided Breast BiopsyNational determinationOn the books220.13Updated Sep 9, 2025
- Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)Local determinationIn effectL39851Palmetto GBAUpdated Oct 7, 2026
- Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)Local determinationIn effectL39863Wellpoint FederalUpdated Jul 14, 2026
- Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT )/Coronary Plaque Analysis (AI-CPA)Local determinationIn effectL39881Noridian Healthcare Solutions, LLCUpdated Oct 7, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Guidance", any status and sponsor, newest update first.
- NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label DevicesNot yet recruiting
National Heart, Lung, and Blood Institute (NHLBI)NIH
NCT07806149 · 200 participants (planned) · Start Nov 24, 2026 · Primary completion Mar 1, 2029
Device: SESAME Procedure · For: Hypertrophic Cardiomyopathy; Left Ventricular Outflow Obstruction; Systolic Anterior Motion
Sites: Washington D.C., District of Columbia; Atlanta, Georgia; Boston, Massachusetts · 8 sites in all
Sunnybrook Health Sciences CentreAcademic, hospital or other
NCT07113665 · 10 participants (planned) · Start Sep 5, 2025 · Primary completion Aug 2028
Device: ExAblate Neuro 4000 · For: Anorexia Nervosa (DSM-IV Revised Criteria)
Sites: Toronto, Canada
- Photoacoustic Imaging of Foot WoundRecruiting
State University of New York at BuffaloAcademic, hospital or other
NCT07216599 · 25 participants (planned) · Start Oct 28, 2025 · Primary completion Apr 30, 2027
Device: Photoacoustic imaging and multispectral imaging · For: Foot Ulcer
Sites: Buffalo, New York
1,683 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Guidance", and for the whole product code for context.
This brand
463 reports: 299 malfunction, 160 injury, 4 death
Whole product code QJU
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
- Affirm Breast Biopsy Guidance SystemMalfunction
3005496266-2026-00343 · Received Oct 30, 2026 · Event dated Sep 30, 2026
Device type: System, X-Ray, Mammographic (IZH)
Device problem as coded: Malposition of Device; Calibration Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Affirm Breast Biopsy Guidance SystemMalfunction
3005496266-2026-00326 · Received Oct 26, 2026 · Event dated Sep 25, 2026
Device type: System, X-Ray, Mammographic (IZH)
Device problem as coded: Mechanical Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
1723170-2026-01502 · Received Oct 23, 2026 · Event dated Oct 2, 2026
Device type: Neurological Stereotaxic Instrument (HAW)
Device problem as coded: Material Fragmentation; Mechanical Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Guidance"[tiab]. The summary above synthesizes these.
- Good-enough attentional guidance.
Yu X, Zhou Z, Becker SI, et al. · Trends Cogn Sci · 2023Review, Research Support, N.I.H., Extramural
- Anterior guidance: group function/canine guidance. A literature review.
Thornton LJ · J Prosthet Dent · 1990Review
- Dendritic guidance.
Kim S, Chiba A · Trends Neurosci · 2004Research Support, U.S. Gov't, P.H.S., Review
- Enhanced Guidance for Endovascular Robotics.
Kundrat D, Schell A, Bijlsma J, et al. · Annu Int Conf IEEE Eng Med Biol Soc · 2024
- Glycosylation in Axonal Guidance.
Mutalik SP, Gupton SL · Int J Mol Sci · 2021Review
- ASCCP Clinical Guidance Document Standardization.
Marcus JZ, Conageski C, Novetsky AP, et al. · J Low Genit Tract Dis · 2025
- Motor axon guidance in Drosophila.
Arzan Zarin A, Labrador JP · Semin Cell Dev Biol · 2019Review
- Dynamic regulation of axon guidance.
Yu TW, Bargmann CI · Nat Neurosci · 2001Review
- Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures.
Alter KE, Karp BI · Toxins (Basel) · 2017Research Support, N.I.H., Intramural, Review
- Calcium signaling in axon guidance.
Sutherland DJ, Pujic Z, Goodhill GJ · Trends Neurosci · 2014Research Support, Non-U.S. Gov't, Review
- Myotube Guidance: Shaping up the Musculoskeletal System.
Johnson AN · J Dev Biol · 2024Review
- Collective cell migration: guidance principles and hierarchies.
Haeger A, Wolf K, Zegers MM, et al. · Trends Cell Biol · 2015Research Support, Non-U.S. Gov't, Review
Other devices of this type
Also filed under product code QJU.
- HeartFocusDeski · 510(k) 2026
- Caption GuidanceCaption Health · 510(k) 2020
- Lung GuidanceGE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · 510(k) 2026
- ThinkSono GuidanceThinkSono GmbH · 510(k) 2026
- UltraSight GuidanceUltrasight , Ltd. · 510(k) 2025
- UltraSight AI GuidanceUltrasight, Inc. · 510(k) 2023
- Caption GuidanceBay Labs, Inc. · De Novo 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.